L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation

Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation

(2012) S. Bondong et al.   ANNALS OF ONCOLOGY

The impact of race on outcomes of patients with early stage uterine endometrioid carcinoma

(2012) Mohamed A. Elshaikh et al.   GYNECOLOGIC ONCOLOGY

Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer

(2012) Gunjal Garg et al.   GYNECOLOGIC ONCOLOGY

Hazard ratios in cancer clinical trials—a primer

(2012) Krastan B. Blagoev et al.   Nature Reviews Clinical Oncology

Endometrial Carcinomas

(2011) Carla Bartosch et al.   ADVANCES IN ANATOMIC PATHOLOGY

Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma

(2011) Heiner Schäfer et al.   CANCER LETTERS

Myofibroblast-induced tumorigenicity of pancreatic ductal epithelial cells is L1CAM dependent

(2011) Heiner Schäfer et al.   CARCINOGENESIS

Prognostic significance of DNA ploidy in stage I endometrial cancer

(2011) Taejong Song et al.   GYNECOLOGIC ONCOLOGY

Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification

(2011) H.M.J. Werner et al.   GYNECOLOGIC ONCOLOGY

L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma

(2011) Shinji Tsutsumi et al.   JOURNAL OF SURGICAL ONCOLOGY

Clinical Effect of Point Mutations in Myelodysplastic Syndromes

(2011) Rafael Bejar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Therapeutic Antibodies to Human L1CAM: Functional Characterization and Application in a Mouse Model for Ovarian Carcinoma

(2010) S. Wolterink et al.   CANCER RESEARCH

L1CAM malfunction in the nervous system and human carcinomas

(2010) Michael K. E. Schäfer et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer–Results from two randomised studies

(2010) Thomas Hogberg et al.   EUROPEAN JOURNAL OF CANCER

Endometrial Cancer State of the Science Meeting

(2010) Henry C. Kitchener et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Minor Serous and Clear Cell Components Adversely Affect Prognosis in ‘‘Mixed-Type’’ Endometrial Carcinomas: A Clinicopathologic Study of 36 Stage-I Cases

(2010) M. Ruhul Quddus et al.   Reproductive Sciences

Linking L1CAM-mediated signaling to NF-κB activation

(2010) Helena Kiefel et al.   TRENDS IN MOLECULAR MEDICINE

Uterine papillary serous carcinoma: epidemiology, pathogenesis and management

(2009) Amanda Nickles Fader et al.   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Immunophenotypic features of MELF pattern invasion in endometrial adenocarcinoma: evidence for epithelial-mesenchymal transition

(2009) Colin J R Stewart et al.   HISTOPATHOLOGY

Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas

(2009) Monica Huszar et al.   JOURNAL OF PATHOLOGY

L1-CAM in cancerous tissues

(2008) Nancy Gavert et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Validation of intraoperative risk assessment on frozen section for surgical management of endometrial carcinoma

(2008) Daniel Egle et al.   GYNECOLOGIC ONCOLOGY